A look into the link between centrosome amplification and breast cancer

Biomed Pharmacother. 2020 Dec:132:110924. doi: 10.1016/j.biopha.2020.110924. Epub 2020 Oct 28.

Abstract

Centrosome amplification (CA) is a common feature of human tumors, but it is not clear whether this is a cause or a consequence of cancer. The centrosome amplification observed in tumor cells may be explained by a series of events, such as failure of cell division, dysregulation of centrosome cycle checkpoints, and de novo centriole biogenesis disorder. The formation and progression of breast cancer are characterized by genomic abnormality. The centrosomes in breast cancer cells show characteristic structural aberrations, caused by centrosome amplification, which include: an increase in the number and volume of centrosomes, excessive increase of pericentriolar material (PCM), inappropriate phosphorylation of centrosomal molecular, and centrosome clustering formation induced by the dysregulation of important genes. The mechanism of intracellular centrosome amplification, the impact of which on breast cancer and the latest breast cancer target treatment options for centrosome amplification are exhaustively elaborated in this review.

Keywords: Breast cancer; Cancer-specific therapies; Centrosome amplification; Centrosome clustering; Mitosis; Multipolar spindle.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / genetics
  • Breast Neoplasms / metabolism*
  • Breast Neoplasms / pathology
  • Cell Cycle Proteins / genetics
  • Cell Cycle Proteins / metabolism*
  • Centrosome / drug effects
  • Centrosome / metabolism*
  • Centrosome / pathology
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Mitosis
  • Molecular Targeted Therapy
  • Wnt Signaling Pathway

Substances

  • Antineoplastic Agents
  • Cell Cycle Proteins